Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

The global research agenda includes 33 research priorities for bacterial and fungal infections and 7 for drug-resistant ...

Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment ...

Over 200 visitors interacted with each other over themes of drug resistant tuberculosis, extra-pulmonary TB and developments ...

However, most people get infected with TB don’t get sick, according to NCDHSS. That’s because their bodies can fight the ...